Your browser doesn't support javascript.
loading
The value of avian gross pathology in identifying endocrine disrupting properties.
Temple, Diana; Springer, Timothy; Gallagher, Sean; du Hoffmann, Gunther; Wheeler, James R.
Afiliação
  • Temple D; Eurofins EAG Agrosciences, LLC, 8598 Commerce Drive, Easton, MD, 21601, USA.
  • Springer T; Springer Consulting, 29371 Stoney Ridge Circle, Easton, MD, 2160, USA.
  • Gallagher S; Eurofins EAG Agrosciences, LLC, 8598 Commerce Drive, Easton, MD, 21601, USA.
  • du Hoffmann G; Eurofins EAG Agrosciences, LLC, 8598 Commerce Drive, Easton, MD, 21601, USA. Electronic address: GuntherduHoffmann@eurofinsUS.com.
  • Wheeler JR; Corteva Agriscience, 3b Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom.
Regul Toxicol Pharmacol ; 112: 104577, 2020 Apr.
Article em En | MEDLINE | ID: mdl-31978447
ABSTRACT
The European Chemical Agency and European Food Safety Authority recommend that gross pathology findings, from avian reproduction studies, be used to support assessment of potential endocrine disrupting properties of active pesticidal and biocidal substances. In open literature, little information is available on the utility of gross pathology data for informing endocrine evaluations. Here the gross pathology data from historical control groups of 51 northern bobwhite and 51 mallard reproduction tests is analyzed to evaluate the utility of such information. Incidence of gross morphology findings in untreated birds may aid the interpretation of some gross abnormalities, potentially indicative of an endocrine interaction (e.g. reproductive condition). Statistical analysis of the historical control data indicates that gross pathology is not likely to be useful for detecting endocrine effects as abnormalities with relatively high increases in prevalence (more than 20-30%, depending on prevalence in controls) are reliably interpreted as a treatment response. Gross pathology changes are only indicative and not diagnostic of endocrine interactions making it difficult to distinguish gross pathology abnormalities, due to endocrine-mediated effects, from systemic toxicity. This work demonstrates the utility of using historical control analyses to establish the value and properties of selected endpoints for regulatory applications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reprodução / Sistema Endócrino / Disruptores Endócrinos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reprodução / Sistema Endócrino / Disruptores Endócrinos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article